The Biomanufacturing Blog

Subscribe Here!

Enabling Bioprocessing 4.0 with Culture Biosciences and 908 Devices

Bioprocessing 4.0 aims to leverage advanced digital technologies, automation, and data-driven...

Insights from the ESACT Bioprocess Modeling Course 2023

Authored by Mike Khor

In October, I had the privilege to represent Culture Biosciences at the...

Culture Solutions: Systematic & Automated Analysis for Cell Line Screening

Cell line screening and development plays a fundamental role in the biopharmaceutical industry,...

The Mysterious Case of the Missing Glucose

Welcome, dear scientific sleuths, to a tale that will both amuse and enlighten as we unravel the...

InSiliCHO: Modeling Cell Line Dynamics for Process Development

Modeling and simulation can be a powerful tool for bioprocess design. We now present InSiliCHO, an...

Supplementing In-House Bioreactor Capacity to Run High-Throughput DOEs

A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...

Launching Culture’s 5L Reactors: An Interview with CEO Will Patrick

As we launch our 5L bioreactors, our co-founder and CEO Will Patrick reflects on why this is such a...

Introducing a New Cell Line Screening Paradigm

revised December 15, 2022

How empowering cell line engineering groups with Culture's cloud...

Making Bioengineering a Reality: Culture Enables Sestina’s New SynBio Platform

The recent increase in consumer demand for sustainably made products has led to a surge in the...

How Culture Biosciences is Scaling Up: An Interview with Our First Employee

Get to know Collin Edington, Hardware Engineering Manager at Culture and our first employee. Collin...

1 2 3 4 5